Empire Life Investments Inc.
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1640951
Toronto, A6
Position in ARCT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,460,978
-$499,587 QoQ
Shares Held
366,217
-4.5% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#15
of 133 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empire Life Investments Inc. holds $27,170,981 across 5 Biotechnology names. ARCT ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
296,586 | $8,565,403 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
871,692 | $8,560,015 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,640 | $3,805,019 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
471,856 | $3,779,566 | |
| 5 | ARCT |
Arcturus Therapeutics Holdings Inc.
This page
|
366,217 | $2,460,978 |
All Filings in ARCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,460,978 | 366,217 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $2,960,565 | 383,493 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,528,024 | 412,402 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $7,695,686 | 417,563 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,434,796 | 264,012 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,805,386 | 264,909 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,742,487 | 279,463 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $3,497,561 | 150,692 | Shares | Defined | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||